All participants are passive/index funds — no active conviction signal. The cluster likely reflects mechanical index rebalancing or auto-investment flows, not a shared fundamental thesis. Without an active manager catalyst or insider buying, this cluster has negligible predictive value for MBOT. Monitor for a 13D activist or strategic partnership filing for a real signal.
Executive Summary
Three mega-passive institutional buyers (BlackRock, State Street, Fidelity) added Microbot Medical shares during Q3 2025 while one mega-passive seller (Morgan Stanley) exited almost entirely. The net buying is small in absolute dollar terms (buyers added ~$973K; sellers reduced ~$374K) and is dominated by index-fund rebalancing, not conviction-based active management. The $119M micro-cap is unprofitable and pre-commercial, making this a low-signal cluster consistent with passive fund drift rather than a coordinated bullish thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: $599.0K
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | ADD | +52.6% | $1.5M | $686.0K |
| State Street | ADD | +50.5% | $636.0K | $287.0K |
| Fidelity | DOUBLED | +31000% | $948.00 | $945.00 |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | NEAR_EXIT | -95% | $398.0K | -$373.7K |
Key Facts
- Three mega-passive buyers added a net ~$973K in MBOT during Q3 2025; one passive seller reduced ~$374K
- BlackRock increased holdings 52.6% to $1.5M; State Street added 50.5% to $636K; Fidelity grew from a token position to $948
- Morgan Stanley cut its MBOT stake 95% to just $24K, suggesting passive rebalancing rather than a negative thesis
- Aggregate net dollar flow is ~$600K positive — immaterial for a $119M micro-cap
- All participants are mega-passive fund families; no active or activist managers participated
Financial Impact
Net institutional buying of ~$600K (buyers added ~$973K, sellers reduced ~$374K), representing <1% of MBOT's $119M market cap
Risk Factors
- MBOT has a $119M market cap, is pre-revenue, and burns cash — institutional flows this small are noise
- Passive fund additions have no demonstrated alpha for micro-cap biotech/med-device stocks
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MBOT-2025-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.9570 | awaiting T+1 | — | — |
Oct 23, 2026 4d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | — |
Oct 20, 2026 7d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | — |
Oct 6, 2026 21d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | — |
Oct 6, 2026 21d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | — |
Sep 28, 2026 29d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | — |
Aug 11, 2026 11w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | — |
Jul 21, 2026 14w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | — |
Jul 7, 2026 16w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | — |
Jun 30, 2026 17w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers